Natera (NTRA) Stock: Charts & Financials

Natera, Inc.(NTRA)

Medical - Diagnostics & Research · Austin, TX

$410.35+1.88 (+0.46%)

Delayed quote: Oct 2, 2026, 4:00 PM EDT

About Natera, Inc.

Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.

Austin, TX

6,138 employees

www.natera.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Steven Leonard Chapman

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	2.71B	752.75M	696.64M	665.50M	592.18M	546.60M	501.83M	476.06M	439.76M
Cost of Goods Sold	939.25M	267.56M	245.20M	218.68M	207.80M	199.53M	184.61M	176.42M	168.01M
Gross Profit	1.77B	485.19M	451.44M	446.82M	384.38M	347.07M	317.22M	299.64M	271.75M
Gross Profit Margin	65.3%	64.5%	64.8%	67.1%	64.9%	63.5%	63.2%	62.9%	61.8%
Total Operating Expenses	2.06B	560.98M	544.96M	469.60M	481.96M	457.44M	396.39M	364.38M	311.08M
Research & Development	787.38M	228.07M	210.70M	175.19M	173.41M	146.43M	129.08M	129.46M	96.93M
Selling, General & Administrative	1.25B	327.20M	327.94M	291.30M	308.55M	310.55M	266.86M	234.92M	214.15M
Operating Income (EBIT)	-289.67M	-75.79M	-93.52M	-22.79M	-97.58M	-110.37M	-79.18M	-64.74M	-39.34M
Operating Margin	-10.7%	-10.1%	-13.4%	-3.4%	-16.5%	-20.2%	-15.8%	-13.6%	-8.9%
Income Before Tax (EBT)	-252.70M	-67.23M	-84.81M	-13.33M	-87.34M	-100.66M	-66.76M	-55.13M	-30.86M
Interest Income	54.49M	9.45M	9.60M	24.16M	11.28M	10.74M	13.42M	10.91M	11.62M
Interest Expense	9.97M	890K	892K	7.15M	1.04M	1.03M	1.00M	1.29M	3.14M
Other Income/Expense	36.97M	8.56M	8.71M	9.46M	10.24M	9.71M	12.41M	9.61M	8.48M
Net Income	-192.35M	-66.97M	-85.09M	47.26M	-87.54M	-100.94M	-66.94M	-53.77M	-31.59M
Income Tax Expense	-60.35M	-261K	283K	-60.58M	207K	275K	173K	-1.35M	730K
Net Profit Margin	-7.1%	-8.9%	-12.2%	7.1%	-14.8%	-18.5%	-13.3%	-11.3%	-7.2%
EBITDA	-224.30M	-54.60M	-73.29M	-8.69M	-87.72M	-100.51M	-69.94M	-56.95M	-31.14M
EBITDA Margin	-8.3%	-7.3%	-10.5%	-1.3%	-14.8%	-18.4%	-13.9%	-12.0%	-7.1%
Depreciation & Amortization	65.37M	21.19M	20.23M	14.10M	9.86M	9.86M	9.24M	7.79M	8.20M
EPS Basic	-1.36	-0.47	-0.60	0.35	-0.64	-0.74	-0.50	-0.41	-0.26
EPS Diluted	-1.36	-0.47	-0.60	0.35	-0.64	-0.74	-0.50	-0.41	-0.26
Weighted Average Basic Shares	143.28M	143.28M	141.50M	136.72M	137.19M	136.39M	134.75M	124.72M	123.78M
Weighted Average Diluted Shares	143.28M	143.28M	141.50M	136.72M	137.19M	136.39M	134.75M	124.72M	123.78M

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

2.71B

752.75M

696.64M

665.50M

592.18M

546.60M

501.83M

476.06M

439.76M

Cost of Goods Sold

939.25M

267.56M

245.20M

218.68M

207.80M

199.53M

184.61M

176.42M

168.01M

Gross Profit

1.77B

485.19M

451.44M

446.82M

384.38M

347.07M

317.22M

299.64M

271.75M

Gross Profit Margin

65.3%

64.5%

64.8%

67.1%

64.9%

63.5%

63.2%

62.9%

61.8%

Total Operating Expenses

2.06B

560.98M

544.96M

469.60M

481.96M

457.44M

396.39M

364.38M

311.08M

Research & Development

787.38M

228.07M

210.70M

175.19M

173.41M

146.43M

129.08M

129.46M

96.93M

Selling, General & Administrative

1.25B

327.20M

327.94M

291.30M

308.55M

310.55M

266.86M

234.92M

214.15M

Operating Income (EBIT)

-289.67M

-75.79M

-93.52M

-22.79M

-97.58M

-110.37M

-79.18M

-64.74M

-39.34M

Operating Margin

-10.7%

-10.1%

-13.4%

-3.4%

-16.5%

-20.2%

-15.8%

-13.6%

-8.9%

Income Before Tax (EBT)

-252.70M

-67.23M

-84.81M

-13.33M

-87.34M

-100.66M

-66.76M

-55.13M

-30.86M

Interest Income

54.49M

9.45M

9.60M

24.16M

11.28M

10.74M

13.42M

10.91M

11.62M

Interest Expense

9.97M

890K

892K

7.15M

1.04M

1.03M

1.00M

1.29M

3.14M

Other Income/Expense

36.97M

8.56M

8.71M

9.46M

10.24M

9.71M

12.41M

9.61M

8.48M

Net Income

-192.35M

-66.97M

-85.09M

47.26M

-87.54M

-100.94M

-66.94M

-53.77M

-31.59M

Income Tax Expense

-60.35M

-261K

283K

-60.58M

207K

275K

173K

-1.35M

730K

Net Profit Margin

-7.1%

-8.9%

-12.2%

7.1%

-14.8%

-18.5%

-13.3%

-11.3%

-7.2%

EBITDA

-224.30M

-54.60M

-73.29M

-8.69M

-87.72M

-100.51M

-69.94M

-56.95M

-31.14M

EBITDA Margin

-8.3%

-7.3%

-10.5%

-1.3%

-14.8%

-18.4%

-13.9%

-12.0%

-7.1%

Depreciation & Amortization

65.37M

21.19M

20.23M

14.10M

9.86M

9.24M

7.79M

8.20M

EPS Basic

-1.36

-0.47

-0.60

0.35

-0.64

-0.74

-0.50

-0.41

-0.26

EPS Diluted

-1.36

-0.47

-0.60

0.35

-0.64

-0.74

-0.50

-0.41

-0.26

Weighted Average Basic Shares

143.28M

141.50M

136.72M

137.19M

136.39M

134.75M

124.72M

123.78M

Weighted Average Diluted Shares

143.28M

141.50M

136.72M

137.19M

136.39M

134.75M

124.72M

123.78M

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.31B	1.70B	1.08B	820.22M	625.49M	391.00M	302.33M	257.65M
Cost of Goods Sold	810.63M	673.75M	589.83M	456.26M	318.42M	203.62M	175.47M	166.06M
Gross Profit	1.50B	1.02B	492.74M	363.97M	307.07M	187.38M	126.86M	91.60M
Gross Profit Margin	64.8%	60.3%	45.5%	44.4%	49.1%	47.9%	42.0%	35.6%
Total Operating Expenses	1.81B	1.25B	938.99M	905.01M	775.24M	403.66M	243.15M	206.23M
Research & Development	624.11M	404.14M	320.68M	316.42M	264.21M	100.03M	51.36M	51.35M
Selling, General & Administrative	1.18B	841.31M	618.31M	588.59M	511.03M	303.63M	206.18M	154.87M
Operating Income (EBIT)	-309.91M	-222.29M	-446.25M	-541.04M	-468.17M	-216.28M	-116.29M	-114.63M
Operating Margin	-13.4%	-13.1%	-41.2%	-66.0%	-74.8%	-55.3%	-38.5%	-44.5%
Income Before Tax (EBT)	-268.09M	-189.73M	-434.53M	-546.82M	-471.10M	-229.65M	-122.83M	-127.83M
Interest Income	45.89M	43.25M	24.35M	3.54M	5.38M	7.56M	4.15M	N/A
Interest Expense	4.07M	10.69M	12.64M	9.32M	8.30M	15.08M	10.69M	10.48M
Other Income/Expense	41.82M	32.56M	11.71M	-5.78M	-2.92M	-13.37M	-6.54M	-13.21M
Net Income	-208.16M	-190.43M	-434.80M	-547.80M	-471.72M	-229.74M	-124.83M	-128.15M
Income Tax Expense	-59.93M	695K	271K	978K	618K	98K	2.00M	321K
Net Profit Margin	-9.0%	-11.2%	-40.2%	-66.8%	-75.4%	-58.8%	-41.3%	-49.7%
EBITDA	-266.43M	-191.33M	-407.63M	-510.57M	-456.92M	-207.66M	-108.56M	-107.13M
EBITDA Margin	-11.6%	-11.3%	-37.7%	-62.2%	-73.1%	-53.1%	-35.9%	-41.6%
Depreciation & Amortization	43.48M	30.97M	38.62M	30.47M	11.25M	8.61M	7.73M	7.50M
EPS Basic	-1.52	-1.53	-3.78	-5.57	-5.21	-2.84	-1.79	-2.22
EPS Diluted	-1.52	-1.53	-3.78	-5.57	-5.21	-2.84	-1.79	-2.22
Weighted Average Basic Shares	136.72M	124.72M	115.00M	98.41M	90.56M	81.01M	69.56M	57.73M
Weighted Average Diluted Shares	136.72M	124.72M	115.00M	98.41M	90.56M	81.01M	69.56M	57.85M

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Revenue

2.31B

1.70B

1.08B

820.22M

625.49M

391.00M

302.33M

257.65M

Cost of Goods Sold

810.63M

673.75M

589.83M

456.26M

318.42M

203.62M

175.47M

166.06M

Gross Profit

1.50B

1.02B

492.74M

363.97M

307.07M

187.38M

126.86M

91.60M

Gross Profit Margin

64.8%

60.3%

45.5%

44.4%

49.1%

47.9%

42.0%

35.6%

Total Operating Expenses

1.81B

1.25B

938.99M

905.01M

775.24M

403.66M

243.15M

206.23M

Research & Development

624.11M

404.14M

320.68M

316.42M

264.21M

100.03M

51.36M

51.35M

Selling, General & Administrative

1.18B

841.31M

618.31M

588.59M

511.03M

303.63M

206.18M

154.87M

Operating Income (EBIT)

-309.91M

-222.29M

-446.25M

-541.04M

-468.17M

-216.28M

-116.29M

-114.63M

Operating Margin

-13.4%

-13.1%

-41.2%

-66.0%

-74.8%

-55.3%

-38.5%

-44.5%

Income Before Tax (EBT)

-268.09M

-189.73M

-434.53M

-546.82M

-471.10M

-229.65M

-122.83M

-127.83M

Interest Income

45.89M

43.25M

24.35M

3.54M

5.38M

7.56M

4.15M

N/A

Interest Expense

4.07M

10.69M

12.64M

9.32M

8.30M

15.08M

10.69M

10.48M

Other Income/Expense

41.82M

32.56M

11.71M

-5.78M

-2.92M

-13.37M

-6.54M

-13.21M

Net Income

-208.16M

-190.43M

-434.80M

-547.80M

-471.72M

-229.74M

-124.83M

-128.15M

Income Tax Expense

-59.93M

695K

271K

978K

618K

98K

2.00M

321K

Net Profit Margin

-9.0%

-11.2%

-40.2%

-66.8%

-75.4%

-58.8%

-41.3%

-49.7%

EBITDA

-266.43M

-191.33M

-407.63M

-510.57M

-456.92M

-207.66M

-108.56M

-107.13M

EBITDA Margin

-11.6%

-11.3%

-37.7%

-62.2%

-73.1%

-53.1%

-35.9%

-41.6%

Depreciation & Amortization

43.48M

30.97M

38.62M

30.47M

11.25M

8.61M

7.73M

7.50M

EPS Basic

-1.52

-1.53

-3.78

-5.57

-5.21

-2.84

-1.79

-2.22

EPS Diluted

-1.52

-1.53

-3.78

-5.57

-5.21

-2.84

-1.79

-2.22

Weighted Average Basic Shares

136.72M

124.72M

115.00M

98.41M

90.56M

81.01M

69.56M

57.73M

Weighted Average Diluted Shares

136.72M

124.72M

115.00M

98.41M

90.56M

81.01M

69.56M

57.85M

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)